Intellia Therapeutics and Novartis Expand Cell Therapy Collaboration to Pursue CRISPR/Cas9-based Genome Editing in Additional Stem Cell Population

World News: . []

CAMBRIDGE Mass Dec 06 2018 GLOBE NEWSWIRE -- Intellia Therapeutics Inc NASDAQNTLA a leading genome editing company focused on developing curative therapeutics using CRISPRCas9 technology both and announced an expansion of its exis ting ce...

More news and information about Intellia Therapeutics, Inc.

Published By:

Globe Newswire: 12:30 GMT Thursday 6th December 2018

Published: .

Search for other references to "intellia" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us